HPRT1 and neoplasm: Our study found that HPRT1 is highly expressed in many common cancers and corresponds to a poor clinical prognosis, and its malignancy and expression of resistance to CDDP in oral cancer has been identified, but there is very little research on HPRT1 in other tumor areas.